Haleon (NYSE: HLN) reports 8.88B voting shares in latest capital update

Rhea-AI Filing Summary

Haleon plc reports its share capital and voting rights position as at 30 April 2026. The company has issued a total of 8,891,932,595 ordinary shares of £0.01 each, with 12,240,797 held as treasury shares. As a result, 8,879,691,798 ordinary shares carry voting rights. Shareholders and other parties with notification obligations are instructed to use this voting-rights figure as the denominator when calculating whether they must notify their interest in Haleon under the FCA's Disclosure Guidance and Transparency Rules.

Key Figures

Total issued shares: 8,891,932,595 ordinary shares Treasury shares: 12,240,797 ordinary shares Shares with voting rights: 8,879,691,798 ordinary shares +1 more

4 metrics

Total issued shares 8,891,932,595 ordinary shares As at 30 April 2026

Treasury shares 12,240,797 ordinary shares Held by Haleon as at 30 April 2026

Shares with voting rights 8,879,691,798 ordinary shares Denominator for FCA disclosure calculations

Nominal value per share £0.01 per ordinary share Share capital structure

Key Terms

treasury shares, voting rights, denominator, FCA's Disclosure Guidance and Transparency Rules, +1 more

5 terms

treasury shares financial

"of which 12,240,797 are held as treasury shares."

Treasury shares are a company’s own stock that it has repurchased and keeps on its books instead of canceling or leaving in the hands of outside investors. Think of them like coupons a business puts back in a drawer: they don’t vote or receive dividends while held, but they can be reissued later for employee pay or fundraising. For investors this matters because buybacks change the number of shares that count toward earnings and ownership, can boost per‑share metrics, and use corporate cash that might otherwise go to growth or dividends.

voting rights financial

"Therefore, the number of ordinary shares with voting rights is 8,879,691,798"

Voting rights are the ability of shareholders to have a say in important company decisions, like choosing leaders or approving big changes. They matter because they give owners a voice in how the company is run, similar to how voters influence elections, ensuring the company acts in shareholders’ interests.

denominator financial

"this figure should be used by shareholders ... as the denominator for the calculation"

The denominator is the number on the bottom of a fraction that shows the total population or base used to calculate a rate, percentage or ratio — for example, the total shares outstanding when calculating earnings per share, or all trial participants when reporting a safety rate. It matters to investors because changing the denominator (by issuing more shares, changing the population measured, or narrowing the base) can make percentages and per‑unit figures look better or worse even if the underlying raw numbers stay the same, much like changing the size of a pizza makes each slice appear larger or smaller.

FCA's Disclosure Guidance and Transparency Rules regulatory

"determine if they are required to notify their interest ... under the FCA's Disclosure Guidance and Transparency Rules."

The FCA’s disclosure guidance and transparency rules are the UK regulator’s requirements that public companies must share clear, timely and accurate information about their finances, governance and material events with investors and the market. Like a neighborhood noticeboard that keeps everyone informed of important changes, these rules help investors make fair comparisons, avoid surprises and reduce the risk that decisions are based on incomplete or late information.

notifiable interests regulatory

"Notifiable interests in Haleon may be sent to: company.secretary@haleon.com"

Form 6-K: How Foreign Companies Report to the SEC →

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of May 2026

Commission File Number: 001-41411

Haleon plc

(Translation of registrant’s name into English)

Building 5, First Floor, The Heights,

Weybridge, Surrey, KT13 0NY

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXHIBIT INDEX

Exhibit Number	Description
99.1	01 May 2026 - “Total Voting Rights and Capital”

99.1

​

Haleon plc: Total Voting Rights and Capital

01 May 2026: As at 30 April 2026 the total number of shares issued by Haleon plc ("Haleon" or the "Company") is 8,891,932,595 ordinary shares of £0.01 each, of which 12,240,797 are held as treasury shares.

Therefore, the number of ordinary shares with voting rights is 8,879,691,798 and this figure should be used by shareholders (and others with notification obligations) as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

Notifiable interests in Haleon may be sent to: company.secretary@haleon.com

Amanda Mellor

Company Secretary

About Haleon

Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are trusted by more than one billion consumers and are recommended by health professionals around the world.

For more information, please visit www.haleon.com. 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		HALEON PLC (Registrant)
Date: May 01, 2026	By:	/s/ Amanda Mellor
		Name:	Amanda Mellor
		Title:	Company Secretary

FAQ

What is Haleon (HLN) total number of issued shares as of 30 April 2026?

Haleon has issued 8,891,932,595 ordinary shares of £0.01 each as at 30 April 2026. This figure includes all shares, whether in circulation or held in treasury by the company.

How many Haleon (HLN) shares are held in treasury and have no voting rights?

Haleon holds 12,240,797 ordinary shares in treasury as at 30 April 2026. Treasury shares are issued but do not carry voting rights or entitlement to dividends while held by the company.

How many Haleon (HLN) shares carry voting rights for transparency calculations?

Haleon states that 8,879,691,798 ordinary shares carry voting rights. Investors must use this number as the denominator when assessing disclosure obligations under FCA transparency rules.

Why does Haleon (HLN) disclose total voting rights and capital on 6-K?

Haleon discloses total voting rights and capital so shareholders can accurately calculate percentage holdings. This helps determine when they must notify interests or changes under the FCA's Disclosure Guidance and Transparency Rules.

Where should investors send notifiable interests in Haleon (HLN)?

Notifiable interests in Haleon should be sent to company.secretary@haleon.com. This address is provided so shareholders can comply with FCA disclosure requirements when their holdings cross relevant reporting thresholds.